Janaushadhi Kendras accepting orders on WhatsApp and e-mail

▴ medicircle-janaushadhi-kendras-accepting-orders-on-whatsapp-and-email
Jan Aushadhi warehouses are working at full capacity and inhouse residential arrangements have been made for staff.

Amid lockdown many Pradhan Mantri Bharatiya Janaushadhi Kendras(PMBJK) under the Union Ministry of Chemicals and Fertilizers are accepting the orders for medicines on WhatsApp and e-mail, where on the basis of uploaded prescriptions medicines are delivered at the doorsteps of the patients. This novel move is ensuring use of technology for facilitating easier procurement of medicines by the users. Complementing PMBJKs for this initiative Union Minister of Chemicals and Fertilizers Shri DV Sadananda Gowda said, " it is heartening to note that many PMBJKs are using modern communication tools including social media plataforms like Whatsapp to provide better services in effecting faster delivery of essential medicines to the needy."

PMBJKs are working under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana ( PMBJP). At present threre are over 6300 PMBJKs functioning in 726 districts of the country ensuring supply of quality medicines at affordable prices. These medicine are cheaper by about 50% to 90% on an average. In April 2020 around 52,crore Rupees worth of medicine have been supplied throught the country.

In addition, supply arrangements with India Post has also been made for supply to remotely located stores.

Moreover Bureau of Pharma PSUs of India(BPPI) under Department of Pharmaceuticals, Union Ministry of Chemicals & Fertilizers, has paid its vendors within due date for solving their working capital issues for raw material & logistics.

Dedicated Team has been created of BPPI Officers for every State to sort out bottlenecks in supply due to lockdown.

Jan Aushadhi warehouses are working at full capacity and inhouse residential arrangements have been made for staff.

Helpline numbers of BPPI is working to resolve any issues of consumers and store owners.

For maintaining supply of essential Medicines during lock down period, BPPI has issued purchase orders for 178 fast moving medicines in the month of April having MRP of Rs 186.52 cror

Tags : #Coronavirus #JanAushadhiKendras #Lockdown3

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Setback for Organ Transplantion: First Human to Receive Pig Kidney DiesMay 13, 2024
Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024
Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024